Kailash Singh awarded this year’s Johnny Ludvigsson Prize for young researchers
“Since completing his doctorate in 2017 at Uppsala University, Dr Singh has made significant discoveries, including the identification of impaired function of regulatory T cells and reduced levels of the cytokine IL-35 in T1D patients,” reads the justification from Barndiabetesfonden. Photo: Dinesh Nirmalan.
The Swedish Childhood Diabetes Foundation's Johnny Ludvigsson Prize for young researchers was awarded this year to Kailash Singh, Docent of Medical Cell Biology at the Department of Medical Cell Biology. He received the prize for his research on type 1 diabetes.
“It always feels special to receive a reward based on your contributions to advancing medical sciences,” says Kailash Singh, Docent at the Department of Medical Cell Biology. Photo: Dinesh Nirmalan.
Congratulations!
“Thanks a lot!”
How does it feel?
“It always feels special to receive a reward based on your contributions to advancing medical sciences.”
What does the award mean for you and your research?
“Prof. Johnny Ludvigsson is a pioneer in the field of type 1 diabetes. Therefore, receiving the Johnny Ludvigsson Award means a great deal to me, placing even more responsibility on my shoulders. This award also brings renewed enthusiasm and motivates me to continue my work in the field of type 1 diabetes as this award is the sign that my research is worth for a number of families.”
What do you want to achieve with your research?
“My primary goal is to develop a novel treatment for type 1 diabetes that can completely cure the disease. I am targeting several molecular pathways, not only to expand insulin-producing cells but also to protect them from immune attack. I hope to achieve this goal in near future.”
Petter Nording Cronsten
The justification of the scientific council of Barndiabetesfonden
“Dr Kailash Singh is awarded the Johnny Ludvigsson Prize for young researchers for his groundbreaking contributions to type 1 diabetes (T1D) research. Since completing his doctorate in 2017 at Uppsala University, Dr Singh has made significant discoveries, including the identification of impaired function of regulatory T cells and reduced levels of the cytokine IL-35 in T1D patients. His work has paved the way for potential new treatments and has been recognised with several prestigious awards. Dr Singh has also expanded his research to include the immune response in various forms of diabetes and autoimmune diseases. His efforts have resulted in several publications and research grants, and he has successfully established his own research group at Uppsala University, further cementing his position as a leading scientist in his field.”